These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23643328)

  • 21. Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.
    Berger A; Edelsberg J; Sanders KN; Alvir JM; Mychaskiw MA; Oster G
    BMC Psychiatry; 2012 Aug; 12():99. PubMed ID: 22856540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial.
    Garrido-Sánchez L; Gómez-Revuelta M; Ortiz-García de la Foz V; Pelayo-Terán JM; Juncal-Ruiz M; Ruiz-Veguilla M; Mayoral-Van Son J; Ayesa-Arriola R; Vázquez-Bourgon J; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2022 Nov; 25(11):900-911. PubMed ID: 35894865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
    Moteshafi H; Stip E
    Expert Opin Drug Saf; 2012 Sep; 11(5):713-32. PubMed ID: 22913713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MB; Bilenberg N; Stenstrøm AD; Pedersen J; Nyvang L; Madsen S; Lauritsen MB; Vernal DL; Thomsen PH; Paludan J; Werge TM; Winge K; Juul K; Gluud C; Skoog M; Wetterslev J; Jepsen JR; Correll CU; Fink-Jensen A; Fagerlund B
    BMC Psychiatry; 2014 Jul; 14():199. PubMed ID: 25015535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Datapoints: The ups and downs of dosing second-generation antipsychotics.
    Citrome L; Jaffe A; Levine J
    Psychiatr Serv; 2007 Jan; 58(1):11. PubMed ID: 17215406
    [No Abstract]   [Full Text] [Related]  

  • 26. Tardive dyskinesia in a patient treated with quetiapine.
    Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
    World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ARIQUELI study: potentiation of quetiapine in bipolar I nonresponders with lithium versus aripiprazole.
    Missio G; Moreno DH; Fernandes F; Bio DS; Soeiro-de-Souza MG; Rodrigues dos Santos D; David DP; Costa LF; Demétrio FN; Moreno RA
    Trials; 2013 Jun; 14():190. PubMed ID: 23805994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.
    Kjelby E; Jørgensen HA; Kroken RA; Løberg EM; Johnsen E
    BMC Psychiatry; 2011 Aug; 11():145. PubMed ID: 21884578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.
    Jensen KG; Correll CU; Rudå D; Klauber DG; Decara MS; Fagerlund B; Jepsen JRM; Eriksson F; Fink-Jensen A; Pagsberg AK
    J Am Acad Child Adolesc Psychiatry; 2019 Nov; 58(11):1062-1078. PubMed ID: 30858012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
    Citrome L; Yang R; Glue P; Karayal ON
    Schizophr Res; 2009 Jun; 111(1-3):39-45. PubMed ID: 19375893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.
    Josiassen RC; Shaughnessy RA; Filymer DM; Donohue AM; Kacso M; Finkel N; Curtis J; Audino B; Skuban N
    Early Interv Psychiatry; 2010 Feb; 4(1):57-63. PubMed ID: 20199481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antipsychotics in pregnancy.
    McCauley-Elsom K; Gurvich C; Elsom SJ; Kulkarni J
    J Psychiatr Ment Health Nurs; 2010 Mar; 17(2):97-104. PubMed ID: 20465753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
    Johnsen E; Jørgensen HA; Kroken RA; Løberg EM
    Eur Psychiatry; 2013 Mar; 28(3):174-84. PubMed ID: 22153730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.
    Ebdrup BH; Skimminge A; Rasmussen H; Aggernaes B; Oranje B; Lublin H; Baaré W; Glenthøj B
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):69-82. PubMed ID: 20701823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study.
    Zimbroff D; Warrington L; Loebel A; Yang R; Siu C
    Int Clin Psychopharmacol; 2007 Nov; 22(6):363-70. PubMed ID: 17917555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.